Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report
Main Authors: | Zheng, Miao-yan, Yang, Ju-hong, Shan, Chun-yan, Zhou, Hong-tao, Xu, Yan-guang, Wang, Ying, Ren, Hui-zhu, Chang, Bao-cheng, Chen, Li-ming |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653752/ |
Similar Items
-
Single-dose acarbose decreased glucose-dependent insulinotropic peptide and glucagon levels in Chinese patients with newly diagnosed type 2 diabetes mellitus after a mixed meal
by: Chen, Zhong, et al.
Published: (2016) -
Comparison of Acarbose and Metformin on Albumin Excretion in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial
by: Pan, Qingrong, et al.
Published: (2016) -
MARCH2: Comparative Assessment of Therapeutic Effects of Acarbose and Metformin in Newly Diagnosed Type 2 Diabetes Patients
by: Wang, Guang, et al.
Published: (2014) -
The Effects of Gliclazide, Metformin, and Acarbose on Body Composition in Patients with Newly Diagnosed Type 2 Diabetes Mellitus☆
by: Wang, Hua, et al.
Published: (2013) -
Effect of Acarbose on Long-Term Prognosis in Acute Coronary Syndromes Patients with Newly Diagnosed Impaired Glucose Tolerance
by: Yun, Peng, et al.
Published: (2016)